Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Epidermal growth factor receptor inhibition attenuates non-alcoholic fatty liver disease in diet-induced obese mice
Sorim Choung, Ji Min Kim, Kyong Hye Joung, et al.
PLoS ONE (2019) Vol. 14, Iss. 2, pp. e0210828-e0210828
Open Access | Times Cited: 55

Showing 1-25 of 55 citing articles:

The Protective Effects of Live and Pasteurized Akkermansia muciniphila and Its Extracellular Vesicles against HFD/CCl4-Induced Liver Injury
Shahrbanoo Keshavarz Azizi Raftar, Fatemeh Ashrafian, Abbas Yadegar, et al.
Microbiology Spectrum (2021) Vol. 9, Iss. 2
Open Access | Times Cited: 114
Lipotoxicity reduces DDX58/Rig-1 expression and activity leading to impaired autophagy and cell death
Karla K. Frietze, Alyssa Brown, Dividutta Das, et al.
Autophagy (2021) Vol. 18, Iss. 1, pp. 142-160
Open Access | Times Cited: 41
Role of epidermal growth factor receptor in liver injury and lipid metabolism: Emerging new roles for an old receptor
Bharat Bhushan, George K. Michalopoulos
Chemico-Biological Interactions (2020) Vol. 324, pp. 109090-109090
Closed Access | Times Cited: 47
Network pharmacology analysis of Chaihu Lizhong Tang treating non-alcoholic fatty liver disease
Meng Zhang, Yuan Yuan, Wenjing Zhou, et al.
Computational Biology and Chemistry (2020) Vol. 86, pp. 107248-107248
Closed Access | Times Cited: 44
Regulation of Energy Metabolism by Receptor Tyrosine Kinase Ligands
Meng Zhao, Yunshin Jung, Zewen Jiang, et al.
Frontiers in Physiology (2020) Vol. 11
Open Access | Times Cited: 43
The role of protein kinases as key drivers of metabolic dysfunction-associated fatty liver disease progression: New insights and future directions
Salah Abdalrazak Alshehade, Mohammed Abdullah Alshawsh, Vikneswaran Murugaiyah, et al.
Life Sciences (2022) Vol. 305, pp. 120732-120732
Closed Access | Times Cited: 25
The identification of metabolites from gut microbiota in NAFLD via network pharmacology
Ki‐Kwang Oh, Haripriya Gupta, Byeong Hyun Min, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 14
Gallic Acid Can Promote Low-Density Lipoprotein Uptake in HepG2 Cells via Increasing Low-Density Lipoprotein Receptor Accumulation
Dongying Zhang, Qixing Zhou, Xiangxuan Yang, et al.
Molecules (2024) Vol. 29, Iss. 9, pp. 1999-1999
Open Access | Times Cited: 5
New and Old Key Players in Liver Cancer
Ángel M. Cuesta, Nerea Palao, Paloma Bragado, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 24, pp. 17152-17152
Open Access | Times Cited: 12
Loss of EGFR contributes to high‐fat diet‐induced nonalcoholic fatty liver disease
Fang Shao, Hao Deng, Wei Zhang, et al.
FEBS Letters (2023) Vol. 597, Iss. 11, pp. 1503-1516
Closed Access | Times Cited: 11
Hepatocellular RECK as a Critical Regulator of Metabolic Dysfunction-associated Steatohepatitis Development
Ryan J. Dashek, Rory P. Cunningham, Christopher L. Taylor, et al.
Cellular and Molecular Gastroenterology and Hepatology (2024) Vol. 18, Iss. 3, pp. 101365-101365
Open Access | Times Cited: 4
The hepatocyte epidermal growth factor receptor (EGFR) pathway regulates the cellular interactome within the liver fibrotic niche
Ester Gonzalez‐Sanchez, Javier Vaquero, Daniel Caballero‐Díaz, et al.
The Journal of Pathology (2024) Vol. 263, Iss. 4-5, pp. 482-495
Open Access | Times Cited: 4
Role of Mig-6 in adipose tissue: Implications for glucose metabolism and insulin resistance
Ji Min Kim, Joung Youl Lim, Sorim Choung, et al.
PLoS ONE (2025) Vol. 20, Iss. 2, pp. e0314289-e0314289
Open Access
Multi-Omics Analysis and Machine Learning-Based Identification of Molecular Signatures for Diagnostic Classification in Liver Disease Types along the Microbiota- Gut-Liver Axis
Betül Cömertpay, Esra Göv
Journal of Clinical and Experimental Hepatology (2025) Vol. 15, Iss. 5, pp. 102552-102552
Closed Access
Caffeine can alleviate non-alcoholic fatty liver disease by augmenting LDLR expression via targeting EGFR
Ye‐Wei Huang, Litian Wang, Meng Zhang, et al.
Food & Function (2023) Vol. 14, Iss. 7, pp. 3269-3278
Closed Access | Times Cited: 10
Perinatal triphenyl phosphate exposure induces metabolic dysfunctions through the EGFR/ERK/AKT signaling pathway: Mechanistic in vitro and in vivo studies
Phum Tachachartvanich, Xylina Rusit, Jason H. Tong, et al.
Ecotoxicology and Environmental Safety (2023) Vol. 269, pp. 115756-115756
Open Access | Times Cited: 9
Maladaptive regeneration and metabolic dysfunction associated steatotic liver disease: Common mechanisms and potential therapeutic targets
Dandan Wu, Stan F.J. van de Graaf
Biochemical Pharmacology (2024) Vol. 227, pp. 116437-116437
Open Access | Times Cited: 3
Proteomic signatures of ambient air pollution and risk of non-alcoholic fatty liver disease: A prospective cohort study in the UK Biobank
Ruxianguli Aimuzi, Zhilan Xie, Yimin Qu, et al.
The Science of The Total Environment (2024) Vol. 957, pp. 177529-177529
Closed Access | Times Cited: 3
Current and emerging strategies for the prevention of hepatocellular carcinoma
Yee Hui Yeo, Manal F. Abdelmalek, Seema A. Khan, et al.
Nature Reviews Gastroenterology & Hepatology (2024) Vol. 22, Iss. 3, pp. 173-190
Closed Access | Times Cited: 3
Construction and analysis of protein-protein interaction network of non-alcoholic fatty liver disease
Athina I. Amanatidou, George Dedoussis
Computers in Biology and Medicine (2021) Vol. 131, pp. 104243-104243
Open Access | Times Cited: 18
Honokiol Prevents Non-Alcoholic Steatohepatitis-Induced Liver Cancer via EGFR Degradation through the Glucocorticoid Receptor—MIG6 Axis
Keiichiro Okuda, Atsushi Umemura, S Umemura, et al.
Cancers (2021) Vol. 13, Iss. 7, pp. 1515-1515
Open Access | Times Cited: 18
SIMPLE Is an Endosomal Regulator That Protects Against NAFLD by Targeting the Lysosomal Degradation of EGFR
Jingjing Song, Yupeng Liu, Juan Wan, et al.
Hepatology (2021) Vol. 74, Iss. 6, pp. 3091-3109
Closed Access | Times Cited: 18
Lack of EGFR catalytic activity in hepatocytes improves liver regeneration following DDC‐induced cholestatic injury by promoting a pro‐restorative inflammatory response
Nerea Lazcanoiturburu, Juan García‐Sáez, Carlos González‐Corralejo, et al.
The Journal of Pathology (2022) Vol. 258, Iss. 3, pp. 312-324
Closed Access | Times Cited: 14
Potential Therapeutic Targets and Promising Agents for Combating NAFLD
Atsushi Umemura, Seita Kataoka, Keiichiro Okuda, et al.
Biomedicines (2022) Vol. 10, Iss. 4, pp. 901-901
Open Access | Times Cited: 13
Investigation of the Potential Mechanism of Alpinia officinarum Hance in Improving Type 2 Diabetes Mellitus Based on Network Pharmacology and Molecular Docking
Xuguang Zhang, Xiangyi Li, Hailong Li, et al.
Evidence-based Complementary and Alternative Medicine (2023) Vol. 2023, Iss. 1
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top